Telemedicine is the remote diagnosis, treatment or prevention of disease using information and communications technology. Most research to date has focused on the use of telemedicine in ophthalmology (teleophthalmology) to diagnose posterior segment diseases, including diabetes, macular degeneration and retinopathy of prematurity (ROP).
Researchers at the Kellogg Eye Center are innovating in this area, working to develop new technologies and methods to diagnose and treat both posterior and anterior segment diseases. Kellogg ophthalmologists are leveraging tools such as telemedicine and home/mobile device diagnostics to enable efficient and effective models of care delivery for conditions including corneal diseases, eyelid tumors and inflammation, glaucoma, diabetic retinopathy, retinopathy of prematurity, and acute vision loss. The Kellogg Eye Center is collaborating closely with other clinical departments and with the community to become the leading center for implementing and evaluating novel approaches to efficient eye care delivery.
For more information about telemedicine at the U-M Kellogg Eye Center, please visit: kellogg.umich.edu/eHealth